New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
08:12 EDTCGIXCancer Genetics to present new renal cell carcinoma study data
Cancer Genetics announced that a poster highlighting preliminary results of a study in clear cell Renal Cell Carcinoma will be presented at the 105th Annual Meeting of the American Association of Cancer Research.
News For CGIX From The Last 14 Days
Check below for free stories on CGIX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
08:32 EDTCGIXCancer Genetics IVD for cervical cancer receives CE Mark
Cancer Genetics announced that their proprietary DNA-probe based test for cervical cancer, or FHACT, has received the CE Marking. The CE marking indicates the test's compliance with European Union product safety legislation and allows FHACT to be sold freely within the European Economic Area, or EEA, which includes the 28 member states of the EU as well as the European Free Trade Association. Cancer Genetics' proprietary FHACT test, which can identify irreversible genomic changes associated with progression to cancer, adds predictive value to this screening protocol. In addition to identifying those women most at risk for cervical disease, it can help reduce unnecessary, invasive testing and over-treatment in women who do not show the genomic abnormalities associated with disease progression.
August 27, 2014
08:02 EDTCGIXCancer Genetics' proprietary tests added to NIH's genetic testing registry
Subscribe for More Information
August 25, 2014
08:01 EDTCGIXCancer Genetics announces collaboration to identify, evaluate DLBCL markers
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use